(Q37050411)

17 August 2017

Plasma DOPA levels and growth hormone response to levodopa in parkinsomism (English)

1 reference

17 August 2017

1 reference

3

Marsden CD

1 reference

17 August 2017

Galea-Debono A

1

1 reference

17 August 2017

Jenner P

2

1 reference

17 August 2017

Parkes JD

4

1 reference

17 August 2017

Tarsy D

5

1 reference

17 August 2017

Walters J

6

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 February 1977

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

17 August 2017

1 reference

17 August 2017

40

1 reference

17 August 2017

2

1 reference

17 August 2017

162-167

1 reference

Effect of levodopa (L-DOPA) on human hypophyseal tropic hormone release

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

L-dopa therapy in Parkinson's disease: a critical review of nine years' experience

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

Defective Release of Growth Hormone in Parkinsonism Improved by Levodopa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

Growth Hormone Responses to L-Dopa in Depressed Patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

Protein Intake and Treatment of Parkinson's Disease with Levodopa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

Treatment of Parkinson's disease with aporphines. Possible role of growth hormone

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

Bromocriptine in Parkinsonism.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

Corticosteroid and growth hormone secretion in patients treated with L-dopa.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

Patterns of clinical response and plasma dopa levels in Parkinson's disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492632

A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma

27 June 2018

1 reference

12 December 2020

1 reference

12 December 2020

Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy

1 reference

12 December 2020

An in vitro study of biomechanical changes produced by hypermetabolism and hypometabolism in skeletal muscle

1 reference

12 December 2020

"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine

1 reference

12 December 2020

A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients

1 reference

12 December 2020

1 reference

12 December 2020

Apomorphine: Effect on Growth Hormone

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.40.2.162

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

864480

1 reference